Plerixafor enables successful hematopoietic stem cell collection in an extensively pretreated patient with testicular cancer

Acta Haematologica

Volumn 124, Issue 4, 2010, Pages 235-238

  Saure, Christian ^a   Weigelt, Christian ^a   Schroeder, Thomas ^a   Klärner, Viola ^a   Galonska, Lars ^a   Haas, Rainer ^a   Kobbe, Guido ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

AMD3100; Autologous peripheral blood stem cell transplantation; Autologous stem cell mobilization; CD34+ cells; CXCR4; Germ cell tumor; Hematopoietic progenitor cells; Plerixafor

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CISPLATIN; ETOPOSIDE; GEMCITABINE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; PACLITAXEL; PEGYLATED GRANULOCYTE COLONY STIMULATING FACTOR; PLERIXAFOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CANCER RELAPSE; CANCER SURGERY; CASE REPORT; DRUG MEGADOSE; ENGRAFTMENT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LEUKAPHERESIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; MULTIPLE CYCLE TREATMENT; ORCHIECTOMY; PRIORITY JOURNAL; SALVAGE THERAPY; SEMINOMA; SINGLE DRUG DOSE; STEM CELL MOBILIZATION;

ADULT; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HETEROCYCLIC COMPOUNDS; HUMANS; MALE; RECEPTORS, CXCR4; TESTICULAR NEOPLASMS; TREATMENT OUTCOME;

EID: 78449257160     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000321509     Document Type: Article

References (18)

1. Kondagunta GV, Bacik J, Sheinfeld J, Bajorin D, Bains M, Reich L, Deluca J, Budnick A, Ishill N, Mazumdar M, Bosl GJ, Motzer RJ: Paclitaxel plus ifosfamide followed by highdose carboplatin plus etoposide in previously treated germ cell tumors. J Clin Oncol 2007; 25: 85-90.
2. Einhorn LH, Williams SD, Chamness A, Brames MJ, Perkins SM, Abonour R: Highdose chemotherapy and stem-cell rescue for metastatic germ-cell tumors. N Engl J Med 2007; 357: 340-348.
3. Lorch A, Kollmannsberger C, Hartmann JT, Metzner B, Schmidt-Wolf IG, Berdel WE, Weissinger F, Schleicher J, Egerer G, Haas A, Schirren R, Beyer J, Bokemeyer C, Rick O; German Testicular Cancer Study Group: Single versus sequential high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: a prospective randomized multicenter trial of the German Testicular Cancer Study Group. J Clin Oncol 2007; 25: 2778-2784.
4. Beyer J, Stenning S, Gerl A, Fossa S, Siegert W: High-dose versus conventional-dose chemotherapy as first-salvage treatment in patients with non-seminomatous germ-cell tumors: a matched-pair analysis. Ann Oncol 2002; 13: 599-605.
5. Pico JL, Rosti G, Kramar A, Wandt H, Koza V, Salvioni R, Theodore C, Lelli G, Siegert W, Horwich A, Marangolo M, Linkesch W, Pizzocaro G, Schmoll HJ, Bouzy J, Droz JP, Biron P; Genito-Urinary Group of the French Federation of Cancer Centers (GETUG-FNCLCC), France; European Group for Blood and Marrow Transplantation (EBMT): A randomized trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours. Ann Oncol 2005; 16: 1152-1159.
6. Hohaus S, Martin H, Wassmann B, Egerer G, Haus U, Färber L, Burger KJ, Goldschmidt H, Hoelzer D, Haas R: Recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor (G-CSF and GMCSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cells. Bone Marrow Transplant 1998; 22: 625-630.
7. Kronenwett R, Martin S, Haas R: The role of cytokines and adhesion molecules for mobilization of peripheral blood stem cells. Stem Cells 2000; 18: 320-330.
8. Kobbe G, Bruns I, Fenk R, Czibere A, Haas R: Pegfilgrastim for PBSC mobilization and autologous hematopoietic SCT. Bone Marrow Transplant 2009; 43: 669-677.
9. Chabannon C, Le Corroller AG, Viret F, Eillen C, Faucher C, Moatti JP, Viens P, Vey N, Braud AC, Novakovitch G, Ladaique P, Stoppa AM, Camerlo J, Genre D, Maraninchi D, Blaise D: Cost-effectiveness of repeated aphereses in poor mobilizers undergoing high-dose chemotherapy and autologous hematopoietic cell transplantation. Leukemia 2003; 17: 811-813.
10. Stiff PJ: Management strategies for the hardto- mobilize patient. Bone Marrow Transplant 1999; 23(suppl 2):S29-S33.
11. Majado MJ, Minguela A, González-García C, Salido E, Blanquer M, Funes C, Insausti CL, García-Hernández AM, Moraleda JM, Morales A: Large-volume-apheresis facilitates autologous transplantation of hematopoietic progenitors in poor mobilizer patients. J Clin Apher 2009; 24: 12-17.
12. DiPersio JF, Micallef IN, Stiff PJ, Bolwell BJ, Maziarz RT, Jacobsen E, Nademanee A, McCarty J, Bridger G, Calandra G; 3101 Investigators: Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin's lymphoma. J Clin Oncol 2009; 27: 4767-4773.
13. DiPersio JF, Stadtmauer EA, Nademanee A, Micallef IN, Stiff PJ, Kaufman JL, Maziarz RT, Hosing C, Früehauf S, Horwitz M, Cooper D, Bridger G, Calandra G; 3102 Investigators: Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma. Blood 2009; 113: 5720-5726.
14. Haas R, Möhle R, Frühauf S, Goldschmidt H, Witt B, Flentje M, Wannenmacher M, Hunstein W: Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 1994; 83: 3787-3794.
15. Carral A, de la Rubia J, Martín G, Mollá S, Martínez J, Sanz GF, Soler MA, Jarque I, Jiménez C, Sanz MA: Factors influencing the collection of peripheral blood stem cell collection in patients with acute myeloblastic leukemia and non-myeloid malignancies. Leuk Res 2003; 27: 5-12.
16. Brugger W, Bross K, Frisch J, Dern P, Weber B, Mertelsmann R, Kanz L: Mobilization of peripheral blood progenitor cells by sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following polychemotherapy with etoposide, ifosfamide, and cisplatin. Blood 1992; 79: 1193-1200.
17. Fruehauf S, Veldwijk MR, Seeger T, Schubert M, Laufs S, Topaly J, Wuchter P, Dillmann F, Eckstein V, Wenz F, Goldschmidt H, Ho AD, Calandra G: A combination of granulocytecolony- stimulating factor (G-CSF) and plerixafor mobilizes more primitive peripheral blood progenitor cells than G-CSF alone: results of a European phase II study. Cytotherapy 2009; 11: 992-1001.
18. Broxmeyer HE, Orschell CM, Clapp DW, Hangoc G, Cooper S, Plett PA, Liles WC, Li X, Graham-Evans B, Campbell TB, Calandra G, Bridger G, Dale DC, Srour EF: Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med 2005; 201: 1307-1318. (Pubitemid 40629073)